Bioshield Act Boosts Chemical Fallout Drug Maker.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Reed, Vita
  • Source:
    Orange County Business Journal. 11/29/2004, Vol. 27 Issue 48, p3-48. 2p.
  • Additional Information
    • Subject Terms:
      CENOMED Inc.; DRUG laws; PHARMACEUTICAL policy; CHEMICAL weapons; CHOLINESTERASE inhibitors; BACTERIAL diseases; DRUG approval; TECHNICAL institutes
    • Abstract:
      This article reports that Cenomed Inc., has licensed from the Georgia Institute of Technology the rights to use drug compounds that could be used to treat exposure to chemical agents such as sarin, soman and tabun. The company got a boost in July when President Bush signed the Bioshield Act. The law allots about $5.6 billion over 10 years for the government to stockpile vaccines and drugs to fight anthrax, smallpox and other bioterrorism agents, including ones from chemical weapons. Cenomed's main goal isn't to bring drugs to market. Rather, it hopes to develop drugs that it would license to large pharmaceutical companies that would market them.